Last updated on October 2017

Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects With Moderate to Severe Ulcerative Colitis


Brief description of study

To evaluate safety and efficacy of two dosing regimens in achieving clinical remission in subjects with moderately to severely active Ulcerative Colitis.

Clinical Study Identifier: NCT02065622

Contact Investigators or Research Sites near you

Start Over

AbbVie_Call Center

Kitasato University, Kitasato Institute Hospital /ID# 127001
Tokyo, Japan
  Connect »

AbbVie_Call Center

Medical Hospital of Tokyo Medical and Dental University /ID# 128315
Tokyo, Japan
  Connect »

AbbVie_Call Center

Tokyo Yamate Medical Center /ID# 125201
Tokyo, Japan
  Connect »

AbbVie_Call Center

Kyorin University Hospital /ID# 148184
Mitaka-shi, Japan
7.43miles
  Connect »